IP Verse

Ammelburg, Moritz opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Ammelburg, Moritz

Patent Number:
EP3400947
Title:
Modulation Of Apolipoprotein C-Iii (Apociii) Expression In Lipoprotein Lipase Deficient (Lpld) Populations
Applicant:
IONIS PHARMACEUTICALS, INC.
Opposition Date:
May 22, 2024
Patent Number:
EP3607069
Title:
Products And Compositions
Applicant:
SILENCE THERAPEUTICS GMBH
Opposition Date:
Jul 31, 2023
Patent Number:
EP3895712
Title:
Engineered Natural Killer Cells And Uses Thereof
Applicant:
ONK THERAPEUTICS LIMITED
Opposition Date:
Mar 21, 2023
Patent Number:
EP3213085
Title:
Biomarkers For Risk Prediction Of Mortality
Applicant:
F. HOFFMANN-LA ROCHE AG
Opposition Date:
Sep 12, 2019
Patent Number:
EP3016654
Title:
Tauroursodeoxycholic Acid (Tudca) For Use In The Treatment Of Neurodegenerative Disorders
Applicant:
BRUSCHETTINI S.R.L.
Opposition Date:
Jun 4, 2019

Competitors of Ammelburg, Moritz

BRUSCHETTINI S.R.L.

F. HOFFMANN-LA ROCHE AG

IONIS PHARMACEUTICALS, INC.

Want to track Ammelburg, Moritz?

Feel free to send us a message here and we will get back to you